http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107625787-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 2017-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107625787-B |
| titleOfInvention | A kind of pharmaceutical composition for treating tympanitis |
| abstract | The present invention relates to a kind of pharmaceutical composition for treating tympanitis, which is made of effective component and medically acceptable auxiliary material, which is characterized in that the effective component is made of the raw material of following weight percent: nano silver 30%-60%；Tanshinone IIA 40%-70%；Wherein, the pharmaceutical composition is prepared by following methods: compound is made in nano silver and chitosan, then tanshinone IIA hydroxypropyl-β-cyclodextrin is included into inclusion compound, acquired compound and inclusion compound are then mixed and made into conventional dosage form.Pharmaceutical composition of the present invention not only treats the significant effect of tympanitis, but also has the advantages that flavour of a drug are few, quality is stable, curative for effect. |
| priorityDate | 2017-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.